Seema Nair Parvathy

Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial

Bertrand Routy, John Lenehan, Wilson H. Miller et al. · Nature Medicine · 2023 · 451 citations

Life Sciences, Immunology, Oncology +16

Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial

Laura J. Craven, Adam Rahman, Seema Nair Parvathy et al. · The American Journal of Gastroenterology · 2020 · 326 citations

Life Sciences, Microbiology, Gastroenterology +16

Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial

Philippe Bégin, Jeannie Callum, Erin Jamula et al. · Nature Medicine · 2021 · 275 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +12

Fecal microbiota transplantation is safe and tolerable in patients with multiple sclerosis: A pilot randomized controlled trial

Kait F. Al, Laura J. Craven, Shaeley Gibbons et al. · Multiple Sclerosis Journal - Experimental Translational and Clinical · 2022 · 76 citations · Full text

Life Sciences, Immunology, Microbiology +17

Extended Screening Costs Associated With Selecting Donors for Fecal Microbiota Transplantation for Treatment of Metabolic Syndrome-Associated Diseases

Laura J. Craven, Seema Nair Parvathy, Justin Tat-Ko et al. · Open Forum Infectious Diseases · 2017 · 55 citations · Full text

Medicine, Microbiology, Pharmacoeconomics +10